Rothschild Investment Corp Abb Vie Inc. Transaction History

Rothschild Investment Corp

$1.19 Billion
Q3 2023

A detailed history of Rothschild Investment Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Rothschild Investment Corp holds 127,653 shares of ABBV stock, worth $25.6 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

127,653

Previous 125,913 1.38%

Holding current value

$25.6 Million

Previous $17 Million 12.17%

% of portfolio

1.61%

Previous 1.41%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $232,446 - $269,091	1,740 Added 1.38%	127,653 $19 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $764,450 - $951,308	-5,769 Reduced 4.38%	125,913 $17 Million
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $142,440 - $164,041	985 Added 0.75%	131,682 $21 Million
Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $339,412 - $407,044	2,454 Added 1.91%	130,697 $21.1 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $80,123 - $91,896	597 Added 0.47%	128,243 $17.2 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $844,711 - $1.07 Million	-6,138 Reduced 4.59%	127,646 $19.6 Million
Q1 2022 Apr 18, 2022	SELL	$131.98 - $163.75 $2.12 Million - $2.63 Million	-16,076 Reduced 10.73%	133,784 $21.7 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $1.12 Million - $1.41 Million	-10,404 Reduced 6.49%	149,860 $20.3 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $909,294 - $1.03 Million	-8,546 Reduced 5.06%	160,264 $17.3 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $819,585 - $913,065	-7,790 Reduced 4.41%	168,810 $19 Million
Q1 2021 Apr 15, 2021	SELL	$102.3 - $112.62 $120,714 - $132,891	-1,180 Reduced 0.66%	176,600 $19.1 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $3.27 Million - $4.41 Million	-40,616 Reduced 18.6%	177,780 $19 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $1.03 Million - $1.21 Million	12,047 Added 5.84%	218,396 $19.1 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $29,788 - $39,861	406 Added 0.2%	206,349 $20.3 Million
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $739,750 - $1.12 Million	-11,469 Reduced 5.28%	205,943 $15.7 Million
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $30,655 - $38,356	-425 Reduced 0.2%	217,412 $19.2 Million
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $300,603 - $361,411	4,773 Added 2.24%	217,837 $16.5 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $1.85 Million - $2.37 Million	28,163 Added 15.23%	213,064 $15.5 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $11,802 - $13,890	-153 Reduced 0.08%	184,901 $14.9 Million
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $448,338 - $552,921	5,759 Added 3.21%	185,054 $17.1 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $1.11 Million - $1.23 Million	12,462 Added 7.47%	179,295 $17 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $2.06 Million - $2.44 Million	22,974 Added 15.97%	166,833 $15.5 Million
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $2.97 Million - $3.98 Million	-32,327 Reduced 18.35%	143,859 $13.6 Million
Q4 2017 Jan 23, 2018	SELL	$89.56 - $98.21 $1.48 Million - $1.63 Million	-16,547 Reduced 8.59%	176,186 $17 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $13.5 Million - $17.2 Million	192,733	192,733 $17.1 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Account

Rothschild Investment Corp Abb Vie Inc. Transaction History